14 results
8-K
EX-99.3
SQZB
SQZ Biotechnologies Co
9 Dec 21
Other Events
7:30am
SQZ eAPCs PBMC + mRNA Chronic Hepatitis B Virus Rapid Response Vaccines 9
The Therapeutic Potential and Historical Challenges of Driving CD8 Tumor
8-K
EX-99.2
SQZB
SQZ Biotechnologies Co
13 Sep 21
SQZ Biotechnologies Announces First Autoimmune Disease Indication
6:53am
Indications From Each Platform Autoimmune Disease Chronic Infectious Disease Oncology Annual incidence (‘000s) Prevalence (M) Prevalence (M) 3 3 400 KRAS … Chronic Hepatitis B Virus PBMC + mRNA Rapid Response Vaccines SQZ eAPCs 9 INFECTIOUS AUTO‐ ONCOLOGY DISEASE IMMUNITY
Oncology SQZ™ Approach SQZ eAPCs SQZ
8-K
EX-99.1
SQZB
SQZ Biotechnologies Co
13 Sep 21
SQZ Biotechnologies Announces First Autoimmune Disease Indication
6:53am
Carrier (TAC) platform in autoimmune diseases will be for celiac disease, a chronic autoimmune disorder that afflicts millions of patients and has … disease is a chronic autoimmune disorder that occurs in genetically predisposed people.1 2 The disease is triggered by eating foods containing gluten
10-K
2020 FY
SQZB
SQZ Biotechnologies Co
18 Mar 21
Annual report
6:31am
we are initially developing this platform to potentially provide a curative vaccine for chronic diseases, we believe the SQZ-APC approach could also … to initially develop SQZ APCs for chronic infectious diseases and expect to submit our first IND to the FDA from the infectious disease platform in 2022
424B4
gzf5dasyqfayarcegr
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
rphr3xpmmmk2px3t1l
1 Feb 21
Draft registration statement
12:00am
424B4
9kxgu
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
b5vwz8w hm9ndpgfuo4z
9 Oct 20
IPO registration
4:59pm
DRS/A
knz0lhx4ragq ki0wzc
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
5hu5ghjx8gfg7lo4dmbt
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
ql2kqhw gf
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next